Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 2.63p
   
  • Change Today:
      0.000p
  • 52 Week High: 11.75
  • 52 Week Low: 2.51
  • Currency: UK Pounds
  • Shares Issued: 242.54m
  • Volume: 39,082
  • Market Cap: £6.37m
  • RiskGrade: 429
  • Beta: 0.22

Verici Dx reaches Thermo Fisher collaboration milestone

By Josh White

Date: Monday 01 Jul 2024

LONDON (ShareCast) - (Sharecast News) - Verici Dx, a developer of advanced clinical diagnostics for organ transplants, announced a significant milestone achievement under its agreement with Thermo Fisher Scientific on Monday.
The AIM-traded firm said Thermo Fisher confirmed the successful transfer and completion of all activities related to the pre-transplant prognostic testing technology licensed from Verici Dx.

It said the technology transfer enabled Thermo Fisher Scientific to develop a laboratory-developed test (LDT) in its own laboratories.

The achievement triggered a milestone payment to Verici Dx, as outlined in the global licensing and commercialisation agreement announced on 15 November last year.

Verici said the milestone aligned with previously-disclosed expectations.

"I am delighted to announce this smooth transition between Verici Dx and Thermo Fisher Scientific," said chief executive officer Sara Barrington.

"This collaboration brings together Verici Dx's innovative technology into Thermo Fisher's new CLIA laboratory in the US, which will ultimately benefit patients and the field of organ transplantation."

At 1057 BST, shares in Verici Dx were up 8% at 6.75p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 2.63p
Change Today 0.000p
% Change 0.00 %
52 Week High 11.75
52 Week Low 2.51
Volume 39,082
Shares Issued 242.54m
Market Cap £6.37m
Beta 0.22
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.84% below the market average33.84% below the market average33.84% below the market average33.84% below the market average33.84% below the market average
12% below the sector average12% below the sector average12% below the sector average12% below the sector average12% below the sector average
Price Trend
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
84% below the sector average84% below the sector average84% below the sector average84% below the sector average84% below the sector average
Income Not Available
Growth Not Available

Verici DX Dividends

No dividends found

Trades for 13-Dec-2024

Time Volume / Share Price
15:25 38,640 @ 2.58p
15:13 442 @ 2.51p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page